Monday, March 28, 2011

Greenstone Announces Voluntary Nationwide Recall Of Citalopram And Finasteride Due to Possible Mislabeling

Greenstone Announces Voluntary Nationwide Recall Of Citalopram And Finasteride Due to Possible Mislabeling
Sun, 27 Mar 2011 14:19:00 -0500

Greenstone LLC announced today that it is voluntarily conducting a recall, to the patient level, of medicines with lot number FI0510058-A on the label. This includes Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle), both distributed in the U.S. market.


Manage your FDA Subscriptions:

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

No comments:

Post a Comment